PRQR icon

ProQR Therapeutics

2.46 USD
+0.17
7.42%
At close Updated Oct 14, 4:00 PM EDT
1 day
7.42%
5 days
6.96%
1 month
23.62%
3 months
-0.81%
6 months
108.47%
Year to date
-10.22%
1 year
35.91%
5 years
-46.05%
10 years
-81.26%
 

About: ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Employees: 166

0
Funds holding %
of 7,491 funds
0
Analysts bullish %
of 1 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™